Protecting AuNRs with an enzyme-responsive zwitterionic stealth polypeptide coating in response to matrix metalloproteinase-9 overexpressed in the tumor microenvironment allows them to show a satisfactory systemic circulation half-life, significantly enhancing tumor cell uptake and markedly improving PTT in mouse models [78]. This evidence concerns the gene MMP9 and neoplasm.